Evaluation of Traditional Paper Symptom Diary vs. the VOCEL Mobile Diary
NCT00367263
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Asthma
Interventions
DRUG:
Alvesco (Ciclesonide) 160 ug/day
Sponsor
Allergy & Asthma Medical Group & Research Center